Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NUWE

NUWE - Nuwellis, Inc. Stock Price, Fair Value and News

$3.86+0.03 (+0.78%)
Market Closed

48/100

NUWE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

48/100

NUWE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.26

Target 3M

$2.23

Target 6M

$2.24

NUWE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUWE Price Action

Last 7 days

107.5%

Last 30 days

112.1%

Last 90 days

1.6%

Trailing 12 Months

-92.1%

NUWE RSI Chart

NUWE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NUWE Valuation

Market Cap

6.4M

Price/Earnings (Trailing)

-0.39

Price/Sales (Trailing)

0.78

EV/EBITDA

-0.2

Price/Free Cashflow

-0.68

NUWE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.26

Target 3M

$2.23

Target 6M

$2.24

NUWE Fundamentals

NUWE Revenue

Revenue (TTM)

8.2M

Rev. Growth (Yr)

-6.34%

Rev. Growth (Qtr)

28.52%

NUWE Earnings

Earnings (TTM)

-16.6M

Earnings Growth (Yr)

-80.15%

Earnings Growth (Qtr)

103.73%

NUWE Profitability

EBT Margin

-202.75%

Return on Equity

-423.93%

Return on Assets

-207.5%

Free Cashflow Yield

-146.95%

NUWE Investor Care

Shares Dilution (1Y)

1492.82%

Diluted EPS (TTM)

494.03

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20258.8M8.3M8.2M0
20248.9M9.0M9.0M8.7M
20238.4M8.3M8.7M8.9M
20227.9M7.6M7.8M8.5M
20217.7M8.4M8.3M7.9M
20205.9M6.1M6.8M7.4M
20195.2M5.8M5.6M5.5M
20183.7M3.9M4.3M5.0M
20172.2M3.1M3.5M3.6M
201600543.0K1.3M
2015295.0K295.0K236.0K59.0K
2014118.0K177.0K236.0K295.0K
201300233.0K59.0K
2010000407.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Nuwellis, Inc.

NUWE
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
 CEO
 WEBSITEnuwellis.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES70

Nuwellis, Inc. Frequently Asked Questions

NUWE is the stock ticker symbol of Nuwellis, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Nuwellis, Inc. is 6.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NUWE's fair value in chart for subscribers.

The fair value guage provides a quick view whether NUWE is over valued or under valued. Whether Nuwellis, Inc. is cheap or expensive depends on the assumptions which impact Nuwellis, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUWE.

As of Wed Jan 28 2026, NUWE's PE ratio (Price to Earnings) is -0.39 and Price to Sales (PS) ratio is 0.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUWE PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Nuwellis, Inc. has provided -0.819 (multiply by 100 for percentage) rate of return.